eHealth, Inc. revised earnings guidance for the full year ending December 31, 2023. Total revenue is expected to be in the range of $439 million to $459 million compared to prior guidance of $420 million to $440 million. GAAP net loss is expected to be in the range of $46 million to $26 million compared to prior guidance of $55 million to $35 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.32 USD | +0.76% | -0.84% | -39.05% |
May. 07 | EHealth Shares Jump After Q1 Net Loss Shrinks, Revenue Rises | MT |
May. 07 | Transcript : EHealth, Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.25% | 154M | |
-1.18% | 62.6B | |
+11.89% | 54.79B | |
+5.74% | 25.96B | |
+24.26% | 25.23B | |
+23.57% | 9.13B | |
+24.97% | 6.39B | |
+0.17% | 4.27B | |
+11.71% | 2.24B | |
-19.82% | 1.54B |
- Stock Market
- Equities
- EHTH Stock
- News eHealth, Inc.
- EHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023